Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled study. 1988

G E Hogarty, and J P McEvoy, and M Munetz, and A L DiBarry, and P Bartone, and R Cather, and S J Cooley, and R F Ulrich, and M Carter, and M J Madonia
Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, PA 15213-2593.

Issues regarding the side effects of antipsychotic medication and the possible contribution of the environment to dose requirements led to a two-year controlled dosage study of maintenance antipsychotic medication and familial environment among recently discharged schizophrenic patients. Seventy stable patients, living in high- or low-expressed emotion (EE) households, were randomized, double blind, to receive a standard dose of fluphenazine decanoate (average, 25 mg every two weeks) or a minimal dose representing 20% of the dose prescribed (average, 3.8 mg every two weeks). No differences in relapse were observed among dose, EE, or dose and EE. Patients in the minimal dose/high-EE condition experienced more minor but aborted episodes in year 2. Side effects were fewer on the minimal dose after one year, and low-EE patients were better adjusted than high-EE patients. Over time, minimal-dose recipients were significantly more improved in their instrumental and interpersonal role performance than were standard-dose recipients.

UI MeSH Term Description Entries
D008297 Male Males
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004644 Emotions Those affective states which can be experienced and have arousing and motivational properties. Feelings,Regret,Emotion,Feeling,Regrets
D004777 Environment The external elements and conditions which surround, influence, and affect the life and development of an organism or population. Environmental Impact,Environmental Impacts,Impact, Environmental,Impacts, Environmental,Environments
D005190 Family A social group consisting of parents or parent substitutes and children. Family Life Cycles,Family Members,Family Life Cycle,Family Research,Filiation,Kinship Networks,Relatives,Families,Family Member,Kinship Network,Life Cycle, Family,Life Cycles, Family,Network, Kinship,Networks, Kinship,Research, Family
D005260 Female Females
D005476 Fluphenazine A phenothiazine used in the treatment of PSYCHOSES. Its properties and uses are generally similar to those of CHLORPROMAZINE. Flufenazin,Fluphenazine Hydrochloride,Lyogen,Prolixin,Hydrochloride, Fluphenazine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G E Hogarty, and J P McEvoy, and M Munetz, and A L DiBarry, and P Bartone, and R Cather, and S J Cooley, and R F Ulrich, and M Carter, and M J Madonia
January 1986, Psychopharmacology bulletin,
G E Hogarty, and J P McEvoy, and M Munetz, and A L DiBarry, and P Bartone, and R Cather, and S J Cooley, and R F Ulrich, and M Carter, and M J Madonia
January 2002, Schizophrenia bulletin,
G E Hogarty, and J P McEvoy, and M Munetz, and A L DiBarry, and P Bartone, and R Cather, and S J Cooley, and R F Ulrich, and M Carter, and M J Madonia
July 1989, The British journal of psychiatry. Supplement,
G E Hogarty, and J P McEvoy, and M Munetz, and A L DiBarry, and P Bartone, and R Cather, and S J Cooley, and R F Ulrich, and M Carter, and M J Madonia
June 1987, Archives of general psychiatry,
G E Hogarty, and J P McEvoy, and M Munetz, and A L DiBarry, and P Bartone, and R Cather, and S J Cooley, and R F Ulrich, and M Carter, and M J Madonia
December 1976, Archives of general psychiatry,
G E Hogarty, and J P McEvoy, and M Munetz, and A L DiBarry, and P Bartone, and R Cather, and S J Cooley, and R F Ulrich, and M Carter, and M J Madonia
April 1997, Schizophrenia research,
G E Hogarty, and J P McEvoy, and M Munetz, and A L DiBarry, and P Bartone, and R Cather, and S J Cooley, and R F Ulrich, and M Carter, and M J Madonia
May 1978, Acta psychiatrica Scandinavica,
G E Hogarty, and J P McEvoy, and M Munetz, and A L DiBarry, and P Bartone, and R Cather, and S J Cooley, and R F Ulrich, and M Carter, and M J Madonia
November 1979, Archives of general psychiatry,
G E Hogarty, and J P McEvoy, and M Munetz, and A L DiBarry, and P Bartone, and R Cather, and S J Cooley, and R F Ulrich, and M Carter, and M J Madonia
January 1994, Perspectives in psychiatric care,
G E Hogarty, and J P McEvoy, and M Munetz, and A L DiBarry, and P Bartone, and R Cather, and S J Cooley, and R F Ulrich, and M Carter, and M J Madonia
October 1992, Lancet (London, England),
Copied contents to your clipboard!